This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Neobiotics Ab. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Claes Schalén: Innovator in Antimicrobial Agents
Introduction
Claes Schalén is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of antimicrobial agents, holding a total of 2 patents. His work focuses on developing innovative compounds that can be used in medical applications.
Latest Patents
Schalén's latest patents include "Peptide derivatives useful as antimicrobial agents and for treating wounds." This patent describes a compound with the general formula (I) R—NH—CH[(CH)—NH—C(NH)—NH]-CO—R-A-R. The compound is utilized in pharmaceutical compositions for treating microbial diseases and stimulating eukaryotic cells. Another patent titled "Antimicrobial compounds" relates to compositions comprising a compound based on the general formula (I) R-Arg-R—NH—CH(R)—CH—NH—R—(I) along with a carrier, diluent, or excipient.
Career Highlights
Claes Schalén is associated with Neobiotics AB, where he continues to advance his research in antimicrobial solutions. His work has the potential to impact the medical field significantly, particularly in the treatment of infections and wound care.
Collaborations
Some of his notable coworkers include Anders Grubb and Regina Kasprzykowska. Their collaborative efforts contribute to the innovative research being conducted at Neobiotics AB.
Conclusion
Claes Schalén is a prominent inventor whose work in antimicrobial agents showcases his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for microbial diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile